Could be a nice set up for a short Hopefully this dies ... And doesnt wake up ever again.
Or someone can call another pandemic and then vaccines are about to be taken again right? say 2025?
0%
0%
0%
0%
0%
About Moderna, Inc
Sector
Health Technology
Industry
Biotechnology
CEO
Stéphane Bancel
Website
modernatx.com
Headquarters
Cambridge
Employees
3.9K
Founded
2010
ISIN
US60770K1079
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
MODERNA $305 | Bidding at $220 and $150 Informed Players and speculators at Sub $100 levels are booking gains
we wait for additional drwadowns and re accomodation ACCUMULATION of designated Bankers for the next run up OR cycle
Vaccine COViD was intense HiV was the sell on News..
we await next Drama and Biden Policy on Healthcare etc..
May Gainers (MRNA, account up 0.25%)10th trade in May is NASDAQ:MRNA .
Holding period is 22 days (5/1/23 - 5/23/23).
Account is up 0.25%.
Total return in May is 3.83%.
Profits Over Patients: The Morally Complex Realm of Big PharmaThis strategy dissects the dual nature of big pharmaceutical firms like Johnson & Johnson, Pfizer, Moderna, and Merck & Co viewed through base Fibonacci Extension Clustering. Despite big pharma's significant contributions to healthcare, these firms have benefited from questionable practices, inclu
Good context for short selling ?support zone become resistance zone also context is looking good for short selling
price is below weekly and monthly VWAP
m30 chart show bearish engulfing to confirm entry
so this level is OK to short
MRNA Short with resistance at 145.50I plan a short trade ( NASDAQ:MRNA ) at 144.41. The entry is just before the resistance zone at ~145.50 which is also confirmed by the Fibonacci 0.5 level. At 146.69 is the stop loss placed so that there is enough space to breathe. The take profit is very conservatively placed at a risk-reward rat
MRNA ? Buy Weakness MRNA descended this past winter off a head-and-shoulders pattern on the daily chart just under
the demand zone as shown by the LuxAlgo indicator. Price is now in a downtrend heading into
earnings tomorrow. MRNA needs to show something good otherwise it will break through the
demand zone and
MRNA finish corrective yet?MRNA m30 show diagonal corrective pattern
divergence and gap down on pre-market
Moderna Very Bearish (Pt 2)Part 1:
The136.50 target was hit and Moderna is now resting at a critical neckline area which bulls have defended for quite some time. I expect a small bounce here but ultimately, a break of this level and a spill much lower. View of the weekly chart below:
This is a head and shoulders within a h
See all ideas
MRNAMiraculous price movement
Moderna looks ready to take on the world, with the efficacy of its new cancer vaccine turning heads.
MRNADelta variant deals pharma stocks a blow
Vaccine stocks spiral as their efficacy against the Delta variant is called into question. Moderna takes the worst of it, down just under 16% to close at $385.33.
MRNAModerna to join S&P 500
Vaccine hero Moderna opens Monday up 6% and finishes the day with a 9.5% bump, building on its share price jump of 10% on Friday on news that the biotech leader is set to get a S&P 500 listing.
See all events
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Gain new superpowers
Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn moreCurated watchlists where MRNA is featured.
